Oncology Biomarkers Market Trends That Will Shape the Next Decade: Insights from Technological Advancements Driving Innovation In Oncology Biomarkers Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Oncology Biomarkers Market Size By 2025?
In the previous years, the oncology biomarkers market size has seen swift expansion. Its growth is predicted to leap from $15.3 billion in 2024 to $17.3 billion in 2025, signaling a compound annual growth rate (CAGR) of 13.0%. Factors that have driven growth in the previous period include the adoption in developing economies, initiatives in precision medicine, innovative diagnostics, support for drug development, and a rising incidence of cancer.

How Big Is the Oncology Biomarkers Market Size Expected to Grow by 2029?
The market for oncology biomarkers is projected to experience a swift expansion in the coming years, with its size anticipated to reach $29.39 billion by 2029, growing at a CAGR of 14.2%. The growth projected for this period is due to the integration of next-generation sequencing (ngs), the growth of biomarker informatics, an emphasis on predictive pharmacogenomics, the swift progress of exosome-based biomarkers, and the adoption of spatial transcriptomics. Future market trends are expected to include standardization and quality assurance, a shift towards functional biomarkers, the role of biomarkers in clinical trials, broader applications in immunotherapy, and real-time monitoring of treatment responses.

View the full report here:
https://www.thebusinessresearchcompany.com/report/oncology-biomarkers-global-market-report

Which Key Market Drivers Powering Oncology Biomarkers Market Expansion and Growth?
The oncology biomarker market is expected to experience significant growth as the frequency of cancer diagnoses continues to rise. Cancer is characterized by the uncontrolled growth of some cells in the body, which, over time, begins to infiltrate the remaining parts of the body. Biomarkers in Oncology offer an advanced understanding of cancer type by analysing genes, proteins, and other substances present in an individual's system. For example, data from the National Library of Medicine, a U.S. government entity, suggests that in 2024 there will be as many as 2,001,140 new incidences of cancer and approximately 611,720 cancer-related fatalities in the United States. Moreover, annually, there has been a 1% to 2% rise in incidence rates of cervical cancer in those aged 30 to 44, and colorectal cancer in people under 55. As such, the increased prevalence of cancer acts as a propelling force for the oncology biomarker market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12493&type=smp

What Are the Key Trends Driving Oncology Biomarkers Market Growth?
The trend of embracing novel and sophisticated technologies is a significant one in the oncology biomarker market. Corporations leading the market of oncology biomarkers are launching ground-breaking technologies to consolidate their market standing. For instance, OncoDNA - a Belgian company with a special focus on precision medication in oncology - unveiled OncoDEEP, an exceptional kit designed to enable labs to carry out comprehensive biomarker testing in 2022. The kit utilizes Next-generation sequencing (NGS) technology and software tools based on cloud to equip laboratories with the capacity to perform large-panel sequencing, secure the molecular characterization of tumors, process the raw data, as well as access comprehensive quality controls.

What Are the Emerging Segments in the Oncology Biomarkers Market?
The oncology biomarkers market covered in this report is segmented -

1) By Biomarker Type: Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers
2) By Profiling Technologies: Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Other Profiling Technologies
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Leukemia, Ovarian Cancer, Liver Cancer, Other Cancer Types
4) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications
5) By End-User: Hospitals, Academic And Cancer Research Institutes, Ambulatory Surgical Centers, Diagnostic Laboratories

Subsegments:
1) By Protein Biomarkers: Tumor-Specific Antigens, Circulating Tumor Cells (CTCs), Enzymatic Biomarkers
2) By Genetic Biomarkers: DNA Mutations, Gene Expression Profiles, Single Nucleotide Polymorphisms (SNPs)
3) By Other Cancer Biomarkers: Metabolomic Biomarkers, Epigenetic Biomarkers, MicroRNA Biomarkers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12493&type=smp

Who Are the Global Leaders in the Oncology Biomarkers Market?
Major companies operating in the oncology biomarkers market include F Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Eli Lilly and Company, Merck KGaA, Siemens Healthcare GmbH, Becton dic*kinson and Company, GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Charles River Laboratories International Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Exact Sciences Corporation, Sysmex Corporation, PerkinElmer Inc., Leica Biosystems, Myriad Genetics Inc., Guardant Health Inc., Enzo Biochem Inc., Biocartis Group NV, Bristol -Myers Squibb Company, Agendia Inc., Epigenomics AG, OncoDNA SA

Which are the Top Profitable Regional Markets for the Oncology Biomarkers Industry?
North America was the largest region in the oncology biomarkers market in 2024. The regions covered in the oncology biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12493

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.